BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16312835)

  • 1. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P; Lagoudis M; Kostis E
    J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.
    Chiuten DF; Carr DT; Dhingra HM; Murphy WK; Spitzer G; Umsawasdi T; Bodey GP; Valdivieso M
    Cancer Treat Rep; 1986 Jun; 70(6):795-6. PubMed ID: 3015403
    [No Abstract]   [Full Text] [Related]  

  • 3. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
    Whitehead RP; Rosenbaum PR; Carbone PP
    Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Taxol in bronchial carcinoma].
    Gatzemeier U
    Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy in non-small cell bronchial carcinoma. 12 years' experience in an international cooperative group: EORTC Lung Cancer Working Party].
    Lacroix H; Sculier JP
    Bull Cancer; 1990; 77(10):997-1005. PubMed ID: 2174277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of chemotherapy in the treatment of advanced stage non-small-cell bronchial cancer].
    Sculier JP
    Rev Mal Respir; 1993; 10(4):287-9. PubMed ID: 8235020
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of unresectable nonsmall-cell lung cancer (NSCLC).
    Papacharalambous A; Rigatos G; Alexopoulos A; Stavrakakis J; Scartsilas C; Stavrinidis E
    J Chemother; 1989 Jul; 1(4 Suppl):1214-5. PubMed ID: 16312839
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
    Bonomi PD; Pazdur R; Stolbach L; Mason B; Ettinger D
    Cancer Treat Rep; 1986 Dec; 70(12):1447-8. PubMed ID: 3024827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of non-small cell bronchopulmonary carcinoma with the combination of cyclophosphamide, adriamycin and cisplatin].
    Donnay Candil O; Jiménez Berlana U
    Rev Esp Oncol; 1983; 30(4):603-10. PubMed ID: 6100970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
    Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A randomized comparison of radiotherapy with CAP and CVP in non-small cell lung cancer].
    Yoneda S; Homma T; Yoshida S; Noguchi Y; Fukuda Y; Nakata M; Sakura M
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2870-1. PubMed ID: 3019254
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
    Laberge F; Desmeules M; Bergeron D; La Forge J; Cormier Y
    Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096
    [No Abstract]   [Full Text] [Related]  

  • 15. Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
    Green MR
    J Clin Oncol; 2008 Jul; 26(19):3112-3. PubMed ID: 18591551
    [No Abstract]   [Full Text] [Related]  

  • 16. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
    Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
    G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bronchial cancer: possibilities and limits of chemotherapy. 2: Non-small cell bronchial cancer].
    Schalhorn A
    Fortschr Med; 1985 May; 103(17):453-6. PubMed ID: 4039699
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy and radiation therapy in lung cancer.
    Sause WT
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):72-8. PubMed ID: 8052877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibilities of chemotherapy in patients with bronchial cancer].
    Hossfeld DK; Zschaber R; Gatzemeier U; Koschel G; Kaukel E; Heilmann HP
    Rontgenblatter; 1988 Mar; 41(3):113-6. PubMed ID: 2838891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV).
    Ruckdeschel JC; Day R; Weissman CH; Stolbach LL; Creech RH
    Cancer Treat Rep; 1984 Nov; 68(11):1325-9. PubMed ID: 6388831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.